Cargando…

Advances and Challenges on Management of Gastrointestinal Stromal Tumors

Gastrointestinal stromal tumors (GISTs) originate from interstitial cells of Cajal and account for over 5,000 newly diagnosed cases in the United States. The discovery of activated KIT and PDGFRA mutations and introduction of imatinib revolutionized the treatment strategy and opened up the new era o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Lin, Du, Wei, Idowu, Michael, von Mehren, Margaret, Boikos, Sosipatros A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949718/ https://www.ncbi.nlm.nih.gov/pubmed/29868467 http://dx.doi.org/10.3389/fonc.2018.00135

Ejemplares similares

Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor
por: Bauer, Sebastian, et al.
Publicado: (2021)

Succinate Dehydrogenase Deficiency in Pediatric and Adult Gastrointestinal Stromal Tumors
por: Belinsky, Martin G., et al.
Publicado: (2013)

ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
por: Rink, Lori, et al.
Publicado: (2013)

An unusual site of metastasis from gastrointestinal stromal tumor
por: Cauchi, Carolina, et al.
Publicado: (2010)

Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors
por: Hu, Xiangchen, et al.
Publicado: (2022)

Role of Surgery in the Management of Liver Metastases From Gastrointestinal Stromal Tumors
por: Xue, Anwei, et al.
Publicado: (2022)

Gastrointestinal Stromal Tumors: Deception to the Eyesight
por: Haddad, Fady G., et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal Tumors
por: Liao, Weiting, et al.
Publicado: (2021)

Apatinib Treatment in Metastatic Gastrointestinal Stromal Tumor
por: Cai, Zhaolun, et al.
Publicado: (2019)

Immunotherapy for Prostate Cancer Enters Its Golden Age
por: Boikos, Sosipatros A., et al.
Publicado: (2012)

Recent advances in the management of gastrointestinal stromal tumors
por: Duffaud, Florence, et al.
Publicado: (2010)

Recent advances in managing gastrointestinal stromal tumor
por: Duffaud, Florence, et al.
Publicado: (2017)

Recent advances in the management of gastrointestinal stromal tumor
por: Ahmed, Monjur
Publicado: (2020)

Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers
por: George, Suzanne, et al.
Publicado: (2022)

An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors
por: Sun, Yingchao, et al.
Publicado: (2022)

Deep learning and radiomics to predict the mitotic index of gastrointestinal stromal tumors based on multiparametric MRI
por: Yang, Linsha, et al.
Publicado: (2022)

Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy
por: George, Suzanne, et al.
Publicado: (2021)

Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors: a real-world, multicenter, observational study
por: Yang, Weili, et al.
Publicado: (2023)

p53 as a biomarker and potential target in gastrointestinal stromal tumors
por: Wu, Chiao-En, et al.
Publicado: (2022)

Latest Advances in the Management of Pediatric Gastrointestinal Stromal Tumors
por: Andrzejewska, Marta, et al.
Publicado: (2022)

Advances of endoscopic and surgical management in gastrointestinal stromal tumors
por: Yue, Lei, et al.
Publicado: (2023)

Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib
por: Janku, Filip, et al.
Publicado: (2020)

Primary extra-gastrointestinal stromal tumor of retroperitoneum: Clinicopathologic characteristics and prognosis of six cases
por: Lin, Jiaxin, et al.
Publicado: (2023)

The Role of Endoscopy in the Diagnosis of Gastric Gastrointestinal Stromal Tumors
por: Nishida, Toshirou
Publicado: (2015)

Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Drug-Resistant Gastrointestinal Stromal Tumors: A Feasibility Study
por: Li, Longhao, et al.
Publicado: (2020)

Hepatitis B Virus Reactivation in Gastrointestinal Stromal Tumor Patients Treated With Imatinib
por: Lei, Tianxiang, et al.
Publicado: (2021)

SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor
por: Pantaleo, Maria A., et al.
Publicado: (2022)

MRI-Based Radiomics Models for Predicting Risk Classification of Gastrointestinal Stromal Tumors
por: Mao, Haijia, et al.
Publicado: (2021)

Editorial: Improving post-surgical outcomes for patients with primary gastrointestinal stromal tumors
por: Koniaris, Leonidas G., et al.
Publicado: (2023)

Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors
por: Zhuang, Chun, et al.
Publicado: (2023)

Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience
por: Lin, Li-Ching, et al.
Publicado: (2022)

Surgical Management of Gastrointestinal Stromal Tumors of the Stomach
por: Bellorin, Omar, et al.
Publicado: (2014)

Ultrasound radiomics model-based nomogram for predicting the risk Stratification of gastrointestinal stromal tumors
por: Zhuo, Minling, et al.
Publicado: (2022)

Automated machine learning to predict the difficulty for endoscopic resection of gastric gastrointestinal stromal tumor
por: Liu, Luojie, et al.
Publicado: (2023)

Gastrointestinal stromal tumors of the small intestine: the challenge of diagnosis and the outcome of management
por: Hamed, Hosam, et al.
Publicado: (2023)

Preoperative CT-Based Deep Learning Model for Predicting Risk Stratification in Patients With Gastrointestinal Stromal Tumors
por: Kang, Bing, et al.
Publicado: (2021)

Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
por: Lin, Li-Ching, et al.
Publicado: (2022)

Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study
por: Zalcberg, John R., et al.
Publicado: (2021)

Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study
por: Bauer, Sebastian, et al.
Publicado: (2021)

Clinical and Prognostic Significance of Tumor-Infiltrating CD8+ T Cells and PD-L1 Expression in Primary Gastrointestinal Stromal Tumors
por: Sun, Xiangfei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_su6s1i3lgnbbl2q1i12n791s5e